Belluscura plc announces that, as anticipated, it has signed its first US distribution agreement for its X-PLO2R™ portable oxygen concentrator ("POC") portfolio. This is the first stage in establishing US-wide distribution coverage as part of the Group's commercialisation strategy. The distributor, located on the East Coast of the United States, is an established nationwide seller of supplemental oxygen equipment. The distributor has immediately issued its first purchase order with anticipated delivery of the first X-PLO2R portable oxygen concentrators expected in Third Quarter of this year. As described in the Company's Admission Document, Belluscura's plan is to appoint distributors in the US to give US-wide coverage for the launch of the X-PLO2R; and this is expected to occur in the second half of 2021 and into 2022.